Douglas B. Given - Feb 27, 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
Director
Signature
/s/Douglass Given
Stock symbol
ARWR
Transactions as of
Feb 27, 2023
Transactions value $
-$28,543
Form type
4
Date filed
3/1/2023, 05:14 PM
Previous filing
Jan 11, 2023
Next filing
May 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Sale -$28.5K -875 -6.31% $32.62 13K Feb 27, 2023 By Trust F1
holding ARWR Common Stock 124K Feb 27, 2023 Direct F2
holding ARWR Common Stock 12.5K Feb 27, 2023 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
F2 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
F3 Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.